World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 11

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3285)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

252

WORD

115

HTML

1350

Figures (1-1)

159

Tables (1-4)

184

Sum=2060

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

351

Download

874

Sum=1225

Nov 27, 2021 (publication date) through May 11, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Fouad M, El Kassas M, Ahmed E, El Sheemy R. Tumor characteristics of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C: Comparative analysis with antiviral therapy-naive patients. World J Hepatol 2021; 13(11): 1743-1752 [PMID: 34904042 DOI: 10.4254/wjh.v13.i11.1743]
URL:	https://www.wjgnet.com/1007-9327/full/v13/i11/1743.htm

Number	Citing Articles
1	Mohamed Elgazzar, Tary Salman, Eman Abdelsameea, Mohamed Akl, Nabil Omar, Mohamed Abdel-Samiee, Shrif Abas, Mohmoud Elsakhawy, Ahmed Elsherif, Ibrahim Abdelkader, Dina Elazab, Nermine Ehsan, Mohamed Mohamady, Mohamed El-Kassas, Hazem Metwaly Omar. Hepatocellular carcinoma in hepatitis C virus patients treated with direct acting antivirals (DAAs) and patients not exposed to DAAs: a large center comparative study. Egyptian Journal of Radiology and Nuclear Medicine 2024; 55(1) doi: 10.1186/s43055-024-01249-4
2	Iman Ibrahim Salama, Hala M Raslan, Ghada A Abdel-Latif, Somaia I Salama, Samia M Sami, Fatma A Shaaban, Aida M Abdelmohsen, Walaa A Fouad. Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection. World Journal of Hepatology 2022; 14(6): 1053-1073 doi: 10.4254/wjh.v14.i6.1053 Abstract(519) \| Core Tip(343) \| Full Article(HTML)(2334) \| Full Article (PDF)-2457K(373) \| Full Article (Word)-310K(85) \| Audio-483K(1) \| Peer-Review Report-238K(54) \| Answering Reviewers-113K(54) \| Times Cited (6) \| Total Visits (6216) \| Open
3	Kazuto Tajiri, Hiroyuki Ito, Kengo Kawai, Yoshiro Kashii, Yuka Hayashi, Aiko Murayama, Masami Minemura, Terumi Takahara, Yukihiro Shimizu, Ichiro Yasuda. Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma. World Journal of Hepatology 2022; 14(6): 1190-1199 doi: 10.4254/wjh.v14.i6.1190 Abstract(508) \| Core Tip(285) \| Full Article(HTML)(1391) \| Full Article (PDF)-2360K(130) \| Full Article (Word)-319K(40) \| Audio-1081K(9) \| Peer-Review Report-221K(50) \| Answering Reviewers-94K(46) \| Supplementary Material-59K(48) \| Times Cited (3) \| Total Visits (5391) \| Open
4	Kelley G. Núñez, Tyler Sandow, Jai Patel, Mina Hibino, Daniel Fort, Ari J. Cohen, Paul Thevenot. Hypoalbuminemia Is a Hepatocellular Carcinoma Independent Risk Factor for Tumor Progression in Low-Risk Bridge to Transplant Candidates. Cancers 2022; 14(7): 1684 doi: 10.3390/cancers14071684